1. Home
  2. VPG vs ASMB Comparison

VPG vs ASMB Comparison

Compare VPG & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

VPG

Vishay Precision Group Inc.

HOLD

Current Price

$44.01

Market Cap

521.6M

Sector

Technology

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$27.84

Market Cap

499.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VPG
ASMB
Founded
2009
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
521.6M
499.8M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
VPG
ASMB
Price
$44.01
$27.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$44.00
$43.40
AVG Volume (30 Days)
256.4K
109.9K
Earning Date
02-11-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.60
N/A
Revenue
$299,283,000.00
$37,191,000.00
Revenue This Year
$0.44
$33.33
Revenue Next Year
$5.01
N/A
P/E Ratio
$73.86
N/A
Revenue Growth
N/A
31.30
52 Week Low
$18.57
$7.75
52 Week High
$50.50
$39.71

Technical Indicators

Market Signals
Indicator
VPG
ASMB
Relative Strength Index (RSI) 60.02 37.34
Support Level $42.15 $25.93
Resistance Level $50.50 $32.31
Average True Range (ATR) 2.47 1.74
MACD 0.35 -0.43
Stochastic Oscillator 45.85 25.06

Price Performance

Historical Comparison
VPG
ASMB

About VPG Vishay Precision Group Inc.

Vishay Precision Group Inc manufactures and markets sensors, and sensor-based measurement systems, as well as specialty resistors and strain gages based on proprietary technology. The company provides precision products and solutions, many of which are designed-in by customers, specializing in the growing markets of stress, force, weight, pressure, and current measurements. The company reports in three product segments: Sensors segment, Weighing Solutions segment, and Measurement Systems segment. It has a business presence in the United States and other countries. It generates the maximum of its revenue from the United States.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: